News

EU regulators start review of China’s Sinovac vaccine

THE HAGUE, Netherlands - The European Union’s drug regulator says it has started a rolling review of China’s Sinovac coronavirus vaccine to assess its effectiveness and safety, a first step toward possible approval for use in the 27-nation bloc.

The European Medicines Agency said Tuesday that its decision to start the review is based on preliminary results from laboratory studies and clinical studies.

“These studies suggest that the vaccine triggers the production of antibodies” that fight the coronavirus “and may help protect against the disease,” the agency said in a statement.

The EMA added that no application has yet been submitted for marketing authorization for the vaccine.

During a rolling review, drugmakers submit their study data in increments instead of waiting for research to be completed in order to speed up the process.
Read more on Toronto Star
News Topics :
Similar Articles :
World
Larger font Increase article font size A+ The European Union’s drug regulator announced Tuesday that it has started a rolling review of China’s Sinovac coronavirus vaccine to assess its effectiveness...
Health
THE HAGUE, NETHERLANDS The European Union s drug regulator announced Tuesday that it has started a rolling review of China s Sinovac coronavirus vaccine to assess its...
World
In this Monday, Feb. 1, 2021, file photo, a woman gets a shot of China s Sinovac CoronaVac vaccine as part of a priority COVID 19 vaccination program for the elderly...
World
MOSCOW The European Medicines Agency said it has started a rolling review of Sputnik V, many months after the vaccine was first approved for use in Russia and after...
World
TAIPEI, Taiwan Chinese vaccine makers are looking at mixing their jabs and whether a booster shot could help better protect against COVID 19. Sinovac and Sinopharm, the two Chinese manufacturers...